Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hormonal Control of Spermatogenesis (ITT-5)
NCT02147964Phase 2Withdrawn
- Sponsor
- University of Washington
- Start
- Jun 2019
- Primary completion
- Dec 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of acyline in hypogonadotropic hypogonadism (HH), sponsored by University of Washington. Planned start Jun 2019; status: withdrawn.
02
Drugs
acyline
03
Conditions
hypogonadotropic hypogonadism (HH)
Beyond the preview
Go deeper on NCT02147964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02147964.